Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Menas, Kizoulis"'
Publikováno v:
Journal of Dermatological Treatment, Vol 34, Iss 1 (2023)
Background The efficacy and safety of an over-the-counter (OTC) 1% colloidal oatmeal cream versus a ceramide-based prescription barrier cream in children with mild-to-moderate atopic dermatitis (AD) were previously described. Objectives Here, finding
Externí odkaz:
https://doaj.org/article/214cf99e370d4d3bb3ad5019f01010c7
Publikováno v:
Journal of the American Academy of Dermatology. 85:AB57
Autor:
Menas Kizoulis, Matthew Richtmyer, Gabriela Oana Cula, Aurélie Coubart, Wendi L. Gardner, Claudia Montoya, Nikoleta Batchvarova
Publikováno v:
Journal of the American Academy of Dermatology. 85:AB70
Publikováno v:
Journal of the American Academy of Dermatology. 83:AB219
Autor:
Joshua D. Williams, Menas Kizoulis
Publikováno v:
Journal of the American Academy of Dermatology. 83:AB217
Autor:
Kurt A, Reynertson, Michelle, Garay, Judith, Nebus, Suhyoun, Chon, Simarna, Kaur, Khalid, Mahmood, Menas, Kizoulis, Michael D, Southall
Publikováno v:
Journal of drugs in dermatology : JDD. 14(1)
Oat (Avena sativa) in colloidal form is a centuries-old topical treatment for a variety of skin conditions, including skin rashes, erythema, burns, itch, and eczema; however, few studies have investigated the exact mechanism of action for the anti-in
Autor:
Connie B, Lin, Nannan, Chen, Richard, Scarpa, Fei, Guan, Laura, Babiarz-Magee, Frank, Liebel, Wen-Hwa, Li, Menas, Kizoulis, Stanley, Shapiro, Miri, Seiberg
Publikováno v:
Pigment cellmelanoma research. 21(2)
The protease-activated receptor-2 (PAR-2) is a seven transmembrane G-protein-coupled receptor that could be activated by serine protease cleavage or by synthetic peptide agonists. We showed earlier that activation of PAR-2 with Ser-Leu-Ile-Gly-Arg-Le